LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Treatments in GI Cosmo Pharmaceuticals focuses on developing innovative treatments for gastro-intestinal diseases including Colon Infections and colorectal cancer prevention, presenting sales opportunities for healthcare providers seeking advanced solutions in this area.

Expansion Through New Personnel The recent appointment of Egle Gedrimaite as Head of Global Business Development indicates Cosmo Pharmaceuticals' focus on expanding its business reach, signaling potential opportunities for partnerships, collaborations, and market growth.

Launch of Winlevi The launch of Winlevi by Cosmo Pharmaceuticals and its submission to the European Medicines Agency (EMA) opens up sales avenues for dermatologists, pharmacies, and healthcare facilities interested in offering this new treatment to patients.

Financially Stable Revenue With a revenue range of $50M - 100M and funding of $25M, Cosmo Pharmaceuticals demonstrates financial stability and growth potential, making it an attractive partner for sales engagements and investment opportunities.

Competitive Advantage in Pharma Compared to similar companies like Aurobindo Pharma, Lupin, and SUN PHARMA in terms of revenue and employee size, Cosmo Pharmaceuticals' niche focus on gastroenterology and endoscopy provides a competitive edge for sales differentiation and market positioning.

Cosmo Pharmaceuticals Tech Stack

Cosmo Pharmaceuticals uses 8 technology products and services including Akamai, Next.js, jQuery UI, and more. Explore Cosmo Pharmaceuticals's tech stack below.

  • Akamai
    Content Delivery Network
  • Next.js
    Javascript Frameworks
  • jQuery UI
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management
  • Nginx
    Web Servers

Cosmo Pharmaceuticals's Email Address Formats

Cosmo Pharmaceuticals uses at least 1 format(s):
Cosmo Pharmaceuticals Email FormatsExamplePercentage
FLast@cosmopharma.comJDoe@cosmopharma.com
48%
FMiddleLast@cosmopharma.comJMichaelDoe@cosmopharma.com
2%
FLast@cosmopharma.comJDoe@cosmopharma.com
48%
FMiddleLast@cosmopharma.comJMichaelDoe@cosmopharma.com
2%

Frequently Asked Questions

Where is Cosmo Pharmaceuticals's headquarters located?

Minus sign iconPlus sign iconCosmo Pharmaceuticals's main headquarters is located at Riverside II Sir John Rogerson’s Quay Dublin 2, Ireland Dublin, Ireland IE. The company has employees across 4 continents, including EuropeAfricaNorth America.

What is Cosmo Pharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Cosmo Pharmaceuticals's main corporate office by phone at
+353-1-817-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cosmo Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconCosmo Pharmaceuticals's official website is cosmopharma.com and has social profiles on LinkedIn.

How much revenue does Cosmo Pharmaceuticals generate?

Minus sign iconPlus sign icon As of October 2024, Cosmo Pharmaceuticals's annual revenue reached $75M.

What is Cosmo Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconCosmo Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cosmo Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of October 2024, Cosmo Pharmaceuticals has approximately 201 employees across 4 continents, including EuropeAfricaNorth America. Key team members include Chief Executive Officer: G. D. N.Chief Scientific Officer: L. M.Chief Manufacturing Officer: R. V.. Explore Cosmo Pharmaceuticals's employee directory with LeadIQ.

What industry does Cosmo Pharmaceuticals belong to?

Minus sign iconPlus sign iconCosmo Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Cosmo Pharmaceuticals use?

Minus sign iconPlus sign iconCosmo Pharmaceuticals's tech stack includes AkamaiNext.jsjQuery UISwiperAmazon Web ServicesX-XSS-ProtectionGoogle Tag ManagerNginx.

What is Cosmo Pharmaceuticals's email format?

Minus sign iconPlus sign iconCosmo Pharmaceuticals's email format typically follows the pattern of . Find more Cosmo Pharmaceuticals email formats with LeadIQ.

How much funding has Cosmo Pharmaceuticals raised to date?

Minus sign iconPlus sign icon As of October 2024, Cosmo Pharmaceuticals has raised $25M in funding. The last funding round occurred on Jun 04, 2020 for $25M.

When was Cosmo Pharmaceuticals founded?

Minus sign iconPlus sign iconCosmo Pharmaceuticals was founded in 1997.
Cosmo Pharmaceuticals

Cosmo Pharmaceuticals

Pharmaceutical ManufacturingIreland, Ireland201-500 Employees

Cosmo Pharmaceuticals improve people's lives by developing innovative treatments that address significant unmet clinical needs and improve clinical outcomes in the field of gastroenterology and endoscopy.

Our clinical development pipeline specifically addresses innovative treatments for gastro-intestinal diseases and Colon Infections.
Our effort is aimed to reduce the incidence of Colorectal Cancer (CRC) by increasing the detection rate of pre-cancerous lesions during colonoscopy. 

Along with our presence in drugs manufacturing, we have significant innovative research and operations supporting our growing portfolio of specialty products. Learn more at www.cosmopharma.com/.

Section iconCompany Overview

Headquarters
Riverside II Sir John Rogerson’s Quay Dublin 2, Ireland Dublin, Ireland IE
Phone number
+353-1-817-****
Website
cosmopharma.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $25M

    Cosmo Pharmaceuticals has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Jun 04, 2020 in the amount of $25M.

  • $50M$100M

    Cosmo Pharmaceuticals's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $25M

    Cosmo Pharmaceuticals has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Jun 04, 2020 in the amount of $25M.

  • $50M$100M

    Cosmo Pharmaceuticals's revenue is in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    G. D. N.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. M.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. V.
    Chief Manufacturing Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. S.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. W.
    Head Of Investor Relations
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    R. V.
    Chief Manufacturing Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. S.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. W.
    Head Of Investor Relations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. D. B.
    Direttore - Svizzera
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. O.
    Director
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.